The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan

The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan

Background To identify the prognostic impact of treatment centralization in patients with testicular germ cell tumors (TGCT). Methods We used a hospital-based cancer registry data in Japan to extract seminoma and non-seminoma cases that were diagnosed in 2013, histologically confirmed, and received...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical oncology 2024-03, Vol.29 (3), p.318-324
Hauptverfasser: Suzuki, Shuhei, Nagumo, Yoshiyuki, Kandori, Shuya, Kojo, Kousuke, Nitta, Satoshi, Chihara, Ichiro, Shiga, Masanobu, Ikeda, Atsushi, Kawahara, Takashi, Hoshi, Akio, Negoro, Hiromitsu, Bryan, Mathis J., Okuyama, Ayako, Higashi, Takahiro, Nishiyama, Hiroyuki
Format: Artikel
Sprache:eng
Schlagworte:
Cancer Research
Hospitals
Humans
Japan - epidemiology
Male
Medicine
Medicine & Public Health
Neoplasm Staging
Neoplasms, Germ Cell and Embryonal - therapy
Oncology
Original Article
Patients
Prognosis
Routinely Collected Health Data
Seminoma
Seminoma - pathology
Seminoma - therapy
Surgical Oncology
Testes
Testicular Neoplasms - pathology
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background To identify the prognostic impact of treatment centralization in patients with testicular germ cell tumors (TGCT). Methods We used a hospital-based cancer registry data in Japan to extract seminoma and non-seminoma cases that were diagnosed in 2013, histologically confirmed, and received the first course of treatment. To compare the 5-years overall survival (OS) rates of patients stratified by institutional care volume, we performed a Cox proportional hazards regression analysis using inverse probability of treatment weighting (IPTW) method to adjust patient backgrounds. Results A total of 1767 TGCT patients were identified. The 5-years OS rates for stage II and III TGCT patients treated at low-volume institutions (
ISSN:1341-9625
1437-7772
DOI:10.1007/s10147-023-02457-0